This page has beta status

CMST COST Action D34
Molecular Targeting and Drug Design in Neurological and Bacterial Diseases

The main objective of the Action is to build on existing knowledge at the chemistry/biology interface, in order to develop new targetoriented molecules and classes of molecules with therapeutic applications in the area of bacterial and neurological diseases. Molecular targeting covers drug design, both on the basis of mechanistic studies and of structural studies of the molecules.

(Descriptions are provided by the Actions directly via e-COST.)


General Information*

Chair of the Action:

Prof Robert R. CRICHTON (BE)

Vice Chair of the Action:

Dr Anne-Marie ALBRECHT-GARY (FR)

Science officer of the Action:

Dr Lucia FORZI

Administrative officer of the Action:

Ms Milena STOYANOVA

Downloads*

Action Fact Sheet

Download AFS as .RTF

Memorandum of Understanding

Download MoU as PDF

Progress Report

Download Progress Report as PDF

Tools

Last updated: 02 May 2011 top of page